Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
暂无分享,去创建一个
G. Kristiansen | D. Dietrich | P. Schaefer | H. Matthaei | P. Lingohr | J. Kalff | V. Branchi | N. Schäfer | A. Semaan | A. Kania | Jörg C. Kalff | G. Kristiansen